Arifa M. P.
- Country
- The Netherlands
- Department
- Pulmonary Medicine
Research Overview
Data & Insights
Has run more than one trial at 2 of 8 partner sites.
Specializations
Lung Cancer Treatment
This investigator specializes in developing innovative therapeutic approaches for non-small cell lung cancer (NSCLC), with particular focus on both early-stage and advanced disease states.
- Advanced NSCLC Management
- Early-Stage NSCLC Treatment
- Combined Therapeutic Approaches
Their research encompasses novel treatment strategies involving immunotherapy applications in various stages of lung cancer.
Immunotherapy Research
The investigator focuses on advancing immunotherapeutic interventions, particularly exploring the effectiveness of agents such as pembrolizumab and durvalumab in lung cancer treatment.
- Monotherapy Applications
- Combination Therapy Strategies
- Immune Response Optimization
Their work includes evaluation of immunotherapy both as standalone treatment and in combination with other therapeutic modalities.
Multimodal Treatment Approaches
The investigator explores integrated treatment strategies combining radiotherapy with immunotherapy and surgical interventions for optimal patient outcomes.
- Neoadjuvant Therapy Development
- Response Rate Assessment
- Tumor Microenvironment Modification
Their research includes investigation of adaptive treatment protocols and therapeutic sequencing in cancer care.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.